Related Experiment Video
Updated: Aug 12, 2026
10:21
Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Hypertrophic and restrictive cardiomyopathies in the elderly
1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Cardiology Clinics
|March 27, 1999
Summary
Congestive heart failure (CHF) in older adults often stems from diastolic dysfunction. This review explores hypertrophic and restrictive cardiomyopathies as models for understanding CHF with preserved systolic function in the elderly.
Area of Science:
- Cardiology
- Geriatrics
- Internal Medicine
Background:
- Congestive heart failure (CHF) prevalence rises with age.
- Diastolic dysfunction is the primary cause of CHF in the elderly, with preserved systolic function.
- Understanding specific cardiomyopathies is crucial for managing elderly CHF patients.
Purpose of the Study:
- To discuss the etiology, pathophysiology, diagnosis, natural history, and treatment of hypertrophic and restrictive cardiomyopathies in the elderly.
- To use these cardiomyopathies as a paradigm for CHF with normal systolic function.
- To compare and contrast hypertrophic obstructive and hypertensive hypertrophic cardiomyopathies.
- To cover amyloidosis as an example of restrictive cardiomyopathy in older patients.
Main Methods:
- Literature review and synthesis of existing research on cardiomyopathies in the elderly.
- Comparative analysis of different hypertrophic cardiomyopathy subtypes.
- Discussion of amyloidosis types and their clinical significance in older individuals.
Main Results:
- Elderly CHF is frequently linked to diastolic dysfunction.
- Hypertrophic and restrictive cardiomyopathies offer insights into CHF with preserved systolic function.
- Amyloidosis represents a key restrictive cardiomyopathy in this demographic.
Conclusions:
- Hypertrophic and restrictive cardiomyopathies are vital models for understanding elderly CHF with preserved systolic function.
- Effective management requires differentiating between various cardiomyopathy subtypes and their specific etiologies.
- Further research into age-related cardiac dysfunction is warranted.
Related Concept Videos
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...